Sentinel Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
BC
RA
FWIA
Sentinel Asset Management's ANGO Position: Q4 2017 in Review
Sentinel Asset Management sold out of AngioDynamics (ANGO) in Q4 2017, closing a stake of 824,201 shares — an estimated $14.1M sold.
Sentinel Asset Management first reported a position in ANGO in Q3 2014 and held it in 13 quarters. The position peaked at $17.4M in Q3 2016. 169 funds tracked by Wall St. Rank hold ANGO as of Q4 2017.
- Sentinel Asset Management reported no remaining AngioDynamics position as of Q4 2017 after selling out during the quarter.
- Sentinel Asset Management sold 824,201 AngioDynamics shares in Q4 2017, an estimated $14.1M.
- Sentinel Asset Management first reported a position in AngioDynamics in Q3 2014 and held it in 13 quarters.
- Sentinel Asset Management's AngioDynamics position peaked at $17.4M in Q3 2016.
- 169 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2017.
Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.